Navigation Links
Fibroblasts invade at a snail's pace
Date:2/2/2009

A transcription factor known to drive the formation of fibroblasts during development also promotes their ability to invade and remodel surrounding tissues, report Rowe et al. in the February 9, 2009 issue of the Journal of Cell Biology.

The conversion of epithelial cells into fibroblast-like mesenchymal cells is a critical event in both normal development and cancer. The transcription factor Snail1 induces this conversion (known as epithelialmesenchymal transition, or EMT) by repressing the expression of epithelial-specific genes. Little was known about Snail1's role after EMT, although the transcription factor is up-regulated in mesenchymal tissue surrounding tumors and wounds.

Because Snail1 expression is thought to be required for maintenance of the mesenchymal phenotype in cancer, Rowe et al. were surprised to see that normal fibroblasts retained many mesenchymal characteristics when Snail1 was removed. The authors did find, however, that many genes important for cell motility, such as actin-binding proteins and matrix metalloproteinases, were expressed at lower levels in fibroblasts lacking Snail1.

Cells invade tissues by sending out actin-rich protrusions called invadopodia that contain proteolytic enzymes that degrade the surrounding extracellular matrix (ECM). Fibroblasts without Snail1 formed fewer invadopodia and were less able to degrade the ECM. Rowe et al. transplanted the Snail1-deficient fibroblasts into chick embryos and found that they were completely unable to penetrate the basement membrane and the complex mix of ECM proteins beneath. Moreover, unlike wild-type fibroblasts, Snail1-deficient cells didn't stimulate the ingrowth of new blood vesselsanother key function of fibroblasts during wound healing and tissue remodeling.

The team thinks that in addition to its role in EMT, Snail1 also acts as a master regulator of fibroblast function. In cancer cells, says author Grant Rowe, sustained Snail1 expression may not only cause a loss of epithelial markers but also promote tumor aggression by stimulating tissue invasion and angiogenesis.


'/>"/>

Contact: Rita Sullivan
rsullivan@rockefeller.edu
212-327-8603
Rockefeller University Press
Source:Eurekalert  

Related medicine news :

1. Radon: The Silent Home Invader That Can Kill
2. Cone snails and plants used to develop oral drug for pain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fibroblasts invade at a snail's pace
(Date:2/27/2017)... ... ... Orange County dentist, Dr. A. Rassouli, comments on the new ... bacteria in plaque infect the gums and other tissues supporting the teeth. Treatment typically ... SRP, and can include surgical therapies if the condition has led to significant damage. ...
(Date:2/27/2017)... ... 2017 , ... Sunshine Coast Health Centre (SCHC), one of ... https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered massage ... commitment to innovation in drug rehab and alcohol treatment strategies beyond a "punishment" ...
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... ... call for entries to the 7th Edition of International Social Design Awards. ... Design Professionals, Product Designers, System Designers, Governments and Institutions worldwide with realized projects ...
(Date:2/26/2017)... Overland Park, KS (PRWEB) , ... ... ... launch of StaffBridge sets a new technology standard in staffing, scheduling, and ... to manage, monitor, and predict activity throughout the entire staffing process. StaffBridge ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... TaskMate Go. Core benefits and advantages built into the home office sit stand ... look and feel. Ability to gain the benefits embedded in the TaskMate Go ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... NEW YORK , Feb. 27, 2017 ... Michael P. Vallely , MBBS, PhD, ... the University of Sydney will be ...  Journal of the American College of ... newer "no-touch" beating heart bypass surgery technique ...
(Date:2/27/2017)... TAMPA, Fla. , Feb. 27, 2017 /PRNewswire/ ... company focused on developing cerebral embolic protection devices ... of the FDA,s Circulatory System Devices Panel that ... the need for cerebral protection following transcatheter aortic ... shared by this FDA panel support the need ...
(Date:2/27/2017)... , February 27, 2017 Now ... the pharmaceutical companies that are most successful at developing and ... ... you gave the same molecule to two different companies in ... Based on systematic, objective analysis of each company,s performance ...
Breaking Medicine Technology: